# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-21-006236
Filing Date
2021-03-17
Accepted
2021-03-16 21:58:21
Documents
67
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | dffn20201231_10k.htm | 10-K | 932972
2 | EXHIBIT 21.1 | ex_234335.htm | EX-21.1 | 6359
3 | EXHIBIT 23.1 | ex_234411.htm | EX-23.1 | 3220
4 | EXHIBIT 31.1 | ex_234412.htm | EX-31.1 | 14964
5 | EXHIBIT 31.2 | ex_234413.htm | EX-31.2 | 14892
6 | EXHIBIT 32.1 | ex_234414.htm | EX-32.1 | 8199
13 |  | dffn20201231_10kimg001.gif | GRAPHIC | 6957
14 |  | dffn20201231_10kimg003.gif | GRAPHIC | 48769
15 |  | dffn20201231_10kimg004.gif | GRAPHIC | 65611
16 |  | dffn20201231_10kimg005.gif | GRAPHIC | 24731
17 |  | dffn20201231_10kimg006.gif | GRAPHIC | 23739
18 |  | rider.jpg | GRAPHIC | 59720
| Complete submission text file | 0001437749-21-006236.txt |  | 4252982

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENT | dffn-20201231.xml | EX-101.INS | 587716
8 | XBRL TAXONOMY EXTENSION SCHEMA | dffn-20201231.xsd | EX-101.SCH | 46270
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dffn-20201231_cal.xml | EX-101.CAL | 35060
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dffn-20201231_def.xml | EX-101.DEF | 297266
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dffn-20201231_lab.xml | EX-101.LAB | 269207
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dffn-20201231_pre.xml | EX-101.PRE | 322600

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 21748270
SIC: 2834 Pharmaceutical Preparations